Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
Article
The Compliance Corner: New Physical Therapy Evaluation Codes for 2017: Moving Toward Value Based Payment
The American Medical Association (AMA) shook up the Property and Casualty industry by bringing a big change to the 2017 Current Procedural Terminol
Workers' Comp
Article
Technology Integrations Are Transforming How Pharmacy Benefits Managers Monitor Drug Therapies
Technology continues to transform the way we live and work, and the insurance industry is no exception.
Mitchell
Article
Winners to be announced at the P&C Conference in October
We are excited to announce the winners of our first annual Mitchell mPower Awards at our P&C conference, October 18, 2017.
WorkCompWire
Article
Cultural Competency and the LGBTQ Injured Worker
Cultural competency has gained a stronger foothold in health care over the past decade.
Workers' Comp
Article
The New CDC Opioid Guidelines
Study and Impact of Guidelines on the Workers’ Compensation Industry
Mitchell
Article
Building a Strong Company Culture For Better Outcomes, Brand Beliefs, and Behaviors.
Culture isn’t accidental.